Effect of GDMT optimization on KDIGO risk categories in HFrEF

11 May 2026 (12:30 - 13:15)

Organised by:

Abstract

Slides

Sign in for access options

About the speaker

Doctor Noel Panagiotides

Medical University of Vienna, Vienna (Austria)

4 More presentations in this session

Presentation thumbnail

Treatment patterns of heart failure patients with reduced or mildly reduced ejection fraction on dapagliflozin: baseline data from the 3rd interim analysis of two EVOLUTION-HF DEallEF study cohorts

Professor M. Paul (Muenster, DE)

Abstract Slides

Presentation thumbnail

Real-word elegibiliy and tolerability of vericiguat in HFrEF: data from a multicenter registry

Associate Professor S. Nodari (Brescia, IT)

Abstract Slides

Presentation thumbnail

Comparison of the 2016 and 2025 ASE/EACVI Guidelines on HFpEF

Miss W. Hu (Hangzhou, CN)

Abstract Slides

Presentation thumbnail

Bridging inequity in HFpEF care: pilot project experience informing the design and implementation of a multidisciplinary blueprint

Doctor M. Lee (Glasgow, GB)

Abstract Slides

Access the full session

Session thumbnail

Challenges and solutions in guideline-directed therapy in heart failure

The Event

Event poster

Heart Failure 2026

11 May 2026 12:30 CET

You may be interested in

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

Webinar

Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

Congress Presentation

Effect of SGLT2 inhibitors in the management of moroccan patients with heart failure with reduced ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources